When the applicant is a legal entity, indication of the name of an officer representing that entity (the indication of such a name is not required where the legal entity is represented by a patent attorney)
If not already complied with, no later than the date on which the relevant time for national processing occurs (refer to paragraph JP.02 of the JP national chapter), the Office will invite the applicant to comply with the requirement within a time limit fixed in the invitation.
Appointment of an agent if the applicant is not resident in Japan
Must be appointed within two months from the date of mailing of the invitation from the Office (refer to paragraph JP.08).
Where the person, the name or the residence of the applicant is changed during the international phase and the change has not been reflected in the international publication or in a Notification of the Recording of a Change (Form PCT/IB/306), a statement indicating the change (preferably on a special request form) and, in case of a change in the person of the applicant, a document evidencing the change
Must be furnished no later than the date on which the relevant time for national processing occurs (refer to paragraph JP.02 of the JP national chapter); if not furnished, the Office will invite the applicant to comply with the requirement within a time limit fixed in the invitation.
Where a change (addition and/or deletion) in the person of the inventor during the international phase has not been reflected in the international publication or in a Notification of the Recording of a Change (Form PCT/IB/306), the correct indications relating to the inventor (preferably on a special transmittal form (Form 53)), a statement explaining the reasons for the change and a written oath of all inventors
Must be furnished no later than the date on which the relevant time for national processing occurs (refer to paragraph JP.02 of the JP national chapter); if not furnished, the Office will invite the applicant to comply with the requirement within a time limit fixed in the invitation.
Furnishing, where applicable, of a nucleotide and/or amino acid sequence listing in electronic form